Home › Amgen, Inc. (AMGN) Upgraded at Morgan Stanley
 

Keywords :   


Amgen, Inc. (AMGN) Upgraded at Morgan Stanley

2015-12-15 02:20:07| Biotech - Topix.net

The firm currently has a $193.00 price target on the medical research company's stock, up from their previous price target of $160.00. Morgan Stanley's price objective indicates a potential upside of 22.07% from the company's previous close.

Tags: morgan stanley upgraded amgen

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Atlantic Tropical Weather Outlook
05.07Eastern North Pacific Tropical Weather Outlook
04.07Hurricane Beryl Graphics
04.07Hurricane Beryl Forecast Discussion Number 25
04.07Hurricane Beryl Public Advisory Number 25
04.07Summary for Hurricane Beryl (AT2/AL022024)
04.07Hurricane Beryl Wind Speed Probabilities Number 25
04.07Hurricane Beryl Forecast Advisory Number 25
More »